We are live on ! Find out more
CPHR

Cipher Pharmaceuticals Inc.
CPHR

Delisted

CPHR was delisted on the 8th of December, 2016.

3 hedge funds and large institutions have $10.1M invested in Cipher Pharmaceuticals Inc. in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% less capital invested

Capital invested by funds: $27.3M → $10.1M (-$17.3M)

83% less funds holding

Funds holding: 183 (-15)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 15

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-15
Holders Change %
-83.33%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
15
Calls
Puts
Net Calls
Net Calls Change

CPHR Hedge Fund Activity: Q4 2016 in Review

3 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q4 2016, worth a combined $10.1M — down 63% from $27.3M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of CPHR and 0 opened new positions — a net loss of 15 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Montrusco Bolton Investments, exiting entirely with an estimated $8.66M sold.

  • 3 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q4 2016, down from 18 in Q3 2016.
  • Funds reported $10.1M of Cipher Pharmaceuticals Inc. stock for Q4 2016, down 63% quarter-over-quarter.
  • 0 funds opened new Cipher Pharmaceuticals Inc. positions in Q4 2016 and 15 closed out, a net change of -15 holders.
  • The largest Cipher Pharmaceuticals Inc. seller in Q4 2016 was Montrusco Bolton Investments, an estimated $8.66M sold.

Based on aggregated 13F filings for Q4 2016.